Theseus Pharmaceuticals
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Theseus Pharmaceuticals's balance sheet done over the years? Its assets were worth $222,447,000 last year, which is less than in the previous period. 7% of Theseus Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $14,832,000, which means an increase by 230% compared compared to last year.

Debt to Assets

Theseus Pharmaceuticals, Inc. (NASDAQ:THRX): Debt to assets
2019 1427000 10.83M 759.22%
2020 8614000 42.88M 497.84%
2021 250929000 4.49M 1.79%
2022 222447000 14.83M 6.67%

THRX Balance Sheet (2019 – 2022)

2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
94.60M244.66M8.45M1.31M
Short term investments
103.37M000
Net receivables
0000
Inventory
0000
Other current assets
4.13M3.30M113K64K
Total current assets
197.97M247.97M8.57M1.38M
Non-current assets:
Property, Plant and Equipment
4.75M11K1K3K
Goodwill
0000
Intangible assets
0000
Long term investments
13.81M379K00
Other non-current assets
5.90M2.56M43K43K
Total non-current assets
24.46M2.95M44K46K
Total assets
222.44M250.92M8.61M1.42M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
0000
Short term debt
743K000
Total current liabilities
11.13M3.68M1.59M615K
Non-current liabilities:
Long term debt
3.23M002.22K
Deferred tax
0000
Other non-current liabilities
466K815K010.21M
Total non-current liabilities
3.70M815K41.28M10.21M
Total liabilities
14.83M4.49M42.88M10.83M
Data sourceData source